RxDoctor Payments Data

Gedge Rosson, MD

Plastic and Reconstructive Surgery · Baltimore, MDNPI 1174553630

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Axogen at 56.2% of the total. That places this record below the midpoint for plastic and reconstructive surgery clinicians in MD, where the typical reported total is $1,639.

$775in general payments, 2019–2025

Across 9 payments — averaging $86.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$435
  • AbbVie$161
  • Checkpoint Surgical, Inc$101
  • Aroa Biosurgery Incorporated$77
$181,285in research payments, 2019–2025

Across 23 payments — averaging $7881.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Axogen$124K
  • AbbVie$57K

What the payments were for

  • Food & beverage$775100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axogen5$435
AbbVie(2 entities)2$161
Checkpoint Surgical, Inc1$101
Aroa Biosurgery Incorporated1$77

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$775 in reported general payments places this provider in the 35th percentile of 55 plastic and reconstructive surgery providers in Maryland.

See all plastic and reconstructive surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$35,801
Medicare patients
69
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →